No Data
No Data
AU Evening Wrap | ASX Surpasses 8200 as Fed Cuts Rates; BHP Rallies on Morgan Stanley Buy Rating
Why Is the ResMed Share Price Taking a Thumping on Thursday?
ResMed Stock Is S&P 500's Worst Performer. GLP-1 Drugs Are a Risk.
ResMed Price Target Announced at $180.00/Share by Wolfe Research
ResMed Cut to Underperform From Peer Perform by Wolfe Research
AU Evening Wrap | ASX Hits Record High Despite Slump in Rio Tinto and BHP
No Data
No Data
151453268 witso : Wow jess you are pulling the trigger and heading for the safe havens, probably good traffic control considering the state of uncertainty our leaders keep promoting, and i use the term leader very loosely. I can only sit tight have a Pepsi and hope my hair doesn’t catch fire. PS more of a coke drinker